Login / Signup

High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies.

Narjis BoukliMelchior Le MeneAurélie SchnurigerNancy Stella CuervoCécilia LarocheLaurence Morand-JoubertJoël Gozlan
Published in: Journal of clinical microbiology (2020)
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • label free
  • risk factors
  • sensitive detection